Valuation: Hofseth BioCare ASA

Market Cap 749M 76.18M 66.56M 61.12M 57M 108M 7.25B 110M 736M 285M 3.56B 286M 280M 12.26B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 1.04B 106M 92.58M 85.01M 79.28M 150M 10.09B 153M 1.02B 397M 4.95B 398M 389M 17.05B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
49.33%
Yield 2024 *
-
Yield 2025 -
1 day-5.92%
1 week+3.85%
Current month-2.17%
1 month+4.65%
3 months-4.26%
6 months-6.90%
Current year+2.27%
1 week 1.23
Extreme 1.23
1.52
1 month 1.1
Extreme 1.1
1.52
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.62
3 years 1.1
Extreme 1.1
3.95
5 years 1.1
Extreme 1.1
8.16
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 65 2009-12-31
Director TitleAgeSince
Director/Board Member 55 2015-04-30
Director/Board Member - -
Director/Board Member - 2021-12-02
Date Insider Type Main position Quantity % Market Cap.
23-07-13Buy 74,000 0.0187%
23-02-27Buy

Chief Technology Officer

200,000 0.0506%
23-02-16Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
-5.92%+3.85%-27.03%-48.47% 76.18M
-0.81%+0.70%+5.38%-22.23% 271B
+2.63%-0.47%-12.44%-16.49% 78.19B
-0.84%+1.69%+6.26%+30.04% 54.19B
+0.23%+0.33%+37.37%+1.63% 37.01B
+2.07%+7.80%+57.97%+113.80% 35.89B
+1.94%+3.09%+2.86%-27.06% 36.95B
+1.44%+8.10%-6.25%-28.54% 30.08B
+0.91%+5.21%+22.20%+28.98% 29.29B
+1.50%-4.56%+30.80%+12.84% 20.66B
Average +0.07%+2.48%+11.71%+4.45% 59.31B
Weighted average by Cap. +0.00%+1.23%+9.25%-3.85%

Financials

2024 2025
Net sales 266M 26.99M 23.59M 21.66M 20.2M 38.29M 2.57B 38.94M 261M 101M 1.26B 101M 99.15M 4.34B 256M 26.06M 22.77M 20.91M 19.5M 36.96M 2.48B 37.59M 252M 97.56M 1.22B 97.84M 95.71M 4.19B
Net income -125M -12.74M -11.13M -10.22M -9.53M -18.07M -1.21B -18.37M -123M -47.69M -595M -47.82M -46.78M -2.05B -135M -13.71M -11.98M -11M -10.26M -19.45M -1.31B -19.78M -132M -51.33M -640M -51.48M -50.36M -2.21B
Net Debt 145M 14.77M 12.91M 11.85M 11.05M 20.95M 1.41B 21.31M 143M 55.3M 690M 55.46M 54.25M 2.38B 293M 29.77M 26.01M 23.89M 22.28M 42.23M 2.83B 42.95M 288M 111M 1.39B 112M 109M 4.79B
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
26-07-03 NOK 1.350 -5.92% 82,490
26-07-02 NOK 1.435 +1.06% 282,570
26-07-01 NOK 1.420 +2.90% 419,645
26-06-30 NOK 1.380 +2.60% 369,475
26-06-29 NOK 1.345 +3.46% 243,658